[ad_1]
NEW YORK (Reuters Health) – US researchers are developing a new treatment that protects against many influenza strains, while the flu virus kills more than 650 people a year because of new strains of the virus that are not not eliminated by the currently available vaccine.
According to a research paper from the Scripps Research Institute, the new vaccine will depend on the stimulation of antibodies in the body to fight viruses.
"Ten years ago, the role of the NPR molecule in strengthening the body's human defenses against the influenza virus was not known, but it can be controlled to induce antibodies in order to Improve protection, "said Ian Wilson, a biologist at the institute.
The vaccine has only been tested on mice to date and has shown a 100% success rate even in mice exposed to lethal levels of the influenza virus.
According to the researchers, the new treatment has shown its effectiveness in treating laboratory-grown lung cells, which could pave the way for launching clinical trials.
"It's an interesting study," said Jesse Bloom, a virus scientist at the Fred Hutchinson Cancer Research Center. "We need extra medicines in our fight against the flu."
[ad_2]
Source link
